Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs EOS Health

Belle Health
Graded #48

Higher grade

vs+14
EOS Health
Graded #269

Lower grade

The verdict

Belle Health takes it — 76.8/100 to 62.8/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +47
91
44
Dose & formulationBelle Health +8
72
64
Clinical oversightEOS Health +16
71
87
Labs & monitoringBelle Health +6
72
66
FulfillmentBelle Health +1
85
84
Contract termsBelle Health +35
55
20
Belle Health · left barEOS Health · right bar

The numbers

MetricBelle HealthEOS Health
WeighScore76.8/10062.8/100
GradeCC
Scorecard rank#48#269
Semaglutide$119/mo$199/mo (compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$289/mo (compounded)
CoverageAll 50 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
EOS Health

Graded #269 · C

Strengths

  • Unusually transparent: publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's)
  • Competitive compounded pricing from $199/mo semaglutide and $289/mo tirzepatide, plus $100 off the first prescription with code WELCOME100
  • Multiple compounded formulas (semaglutide, semaglutide+glycine, semaglutide+B12, tirzepatide) and optional 130+ biomarker lab add-ons
  • Free expedited shipping, no insurance required, 10-minute intake, and an ongoing care team via patient portal

Where it loses points

  • Available in only 40 states — not offered in CA, NV, NJ, SC, TX, MA, MS, NH, WV, or DE (pharmacy partner is unlicensed there)
  • Headline prices are 'best rate' figures; standard monthly plans may cost more than the quarterly-plan rate shown
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path
  • Pharmacy partner's page notes it 'cannot dispense sterile compounds,' which is worth confirming for injectable GLP-1 fulfillment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard